Related Experiment Video
Updated: Jun 19, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Molecular genetic alterations in malignant peripheral nerve sheath tumors
1Institute of Neuropathology, D-39120, Magdeburg, Germany. christian.mawrin@medizin.uni-magdeburg.de
Abstract:
Malignant peripheral nerve sheath tumor is a highly aggressive soft tissue tumor which is derived from neoplastic Schwann cells in most cases. Although sporadic malignant peripheral nerve sheath tumors are infrequent, their occurrence is considerably raised in the setting of neurofibromatosis Type 1. Allelic losses at the neurofibromatosis Type 1 locus on chromosome 17q are the best studied genetic alterations underlying malignant peripheral nerve sheath tumor so far. However, recent studies have suggested that alterations in cell cycle regulators, such as p53, are also involved in malignant peripheral nerve sheath tumor tumorigenesis. This review will focus on new findings about the molecular genetic alterations in both sporadic and neurofibromatosis Type 1-related malignant peripheral nerve sheath tumors, and will discuss their impact on further diagnostic advances, as well as on the clinical course of this tumor.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021